Safety and Effectiveness of Adalimumab for the Treatment of Pyoderma Gangrenosum: A 52-Week Real-World Prospective Observational Study - Quiz - MDSpire

Safety and Effectiveness of Adalimumab for the Treatment of Pyoderma Gangrenosum: A 52-Week Real-World Prospective Observational Study

  • By

  • Toshiyuki Yamamoto

  • Hideaki Tanizaki

  • Kenshi Yamasaki

  • Naoko Matsubara

  • Masahiko Nakayama

  • Eri Iwashita

  • Keiichi Yamanaka

  • May 10, 2026

Share

Original Source(s)

Related Content